. Departamento de Clínica Médica, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte (MG) Brasil.
. Laboratório de Função Pulmonar, Hospital das Clínicas, Universidade Federal de Minas Gerais, Belo Horizonte (MG) Brasil.
J Bras Pneumol. 2020 Mar 2;46(2):e20180198. doi: 10.36416/1806-3756/e20180198. eCollection 2020.
To compare patients with and without previous lung disease, in terms of the spirometry results after they had been treated for pulmonary tuberculosis (PTB) and cured, as well as to analyze risk factors related to functional severity.
This was a cross-sectional, multicenter study conducted at four referral centers in Brazil. Patients were divided into two groups: those with a history of lung disease or smoking (LDS+ group); and those with no such history (LDS- group). Patients underwent spirometry (at least six months after being cured). Sociodemographic and clinical data were collected.
A total of 378 patients were included: 174 (46.1%) in the LDS+ group and 204 (53.9%) in the LDS- group. In the sample as a whole, 238 patients (62.7%) had spirometric changes. In the LDS+ group, there was a predominance of obstructive lung disease (in 33.3%), whereas restrictive lung disease predominated in the LDS- group (in 24.7%). Radiological changes were less common in the LDS- group than in the LDS+ group (p < 0.01), as were functional changes (p < 0.05). However, of the 140 (79.1%) LDS- group patients with a normal or minimally altered chest X-ray, 76 (54%) had functional changes (p < 0.01). The risk factors associated with functional severity in the LDS- group were degree of dyspnea (p = 0.03) and moderate or severe radiological changes (p = 0.01).
Impaired pulmonary function is common after treatment for PTB, regardless of the history of lung disease or smoking. Spirometry should be suggested for patients who develop moderate/severe dyspnea or relevant radiological changes after treatment for PTB.
比较患有和不患有肺部疾病的患者在经过肺结核(PTB)治疗和治愈后的肺功能检测结果,并分析与功能严重程度相关的危险因素。
这是一项在巴西四个转诊中心进行的横断面、多中心研究。患者分为两组:有肺部疾病或吸烟史(LDS+组);无肺部疾病或吸烟史(LDS-组)。患者接受肺功能检测(至少在治愈后 6 个月)。收集社会人口统计学和临床数据。
共纳入 378 例患者:LDS+组 174 例(46.1%),LDS-组 204 例(53.9%)。在整个样本中,238 例(62.7%)患者存在肺功能变化。在 LDS+组中,以阻塞性肺疾病为主(占 33.3%),而在 LDS-组中,以限制性肺疾病为主(占 24.7%)。与 LDS+组相比,LDS-组的影像学变化较少(p < 0.01),功能变化也较少(p < 0.05)。然而,在 LDS-组中,140 例(79.1%)胸部 X 射线正常或轻微改变的患者中有 76 例(54%)存在功能变化(p < 0.01)。LDS-组功能严重程度的相关危险因素是呼吸困难程度(p = 0.03)和中重度影像学变化(p = 0.01)。
无论是否患有肺部疾病或吸烟史,PTB 治疗后肺部功能受损都很常见。对于治疗后出现中度/重度呼吸困难或相关影像学变化的 PTB 患者,应建议进行肺功能检测。